IANNONE, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 3.844
AS - Asia 1.224
EU - Europa 849
SA - Sud America 282
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 6.242
Nazione #
US - Stati Uniti d'America 3.803
SG - Singapore 501
CN - Cina 326
BR - Brasile 251
SE - Svezia 221
RU - Federazione Russa 205
HK - Hong Kong 165
DE - Germania 111
IT - Italia 97
VN - Vietnam 97
GB - Regno Unito 64
FI - Finlandia 33
BE - Belgio 32
IN - India 26
CA - Canada 25
ID - Indonesia 25
FR - Francia 24
BD - Bangladesh 13
PL - Polonia 13
CI - Costa d'Avorio 12
AR - Argentina 11
JP - Giappone 11
MX - Messico 10
TR - Turchia 10
ZA - Sudafrica 9
ES - Italia 8
IQ - Iraq 8
AE - Emirati Arabi Uniti 6
AT - Austria 6
EC - Ecuador 6
MY - Malesia 6
PH - Filippine 6
UA - Ucraina 6
IE - Irlanda 5
KE - Kenya 5
NL - Olanda 5
PK - Pakistan 5
VE - Venezuela 5
RO - Romania 4
UZ - Uzbekistan 4
AU - Australia 3
CO - Colombia 3
DZ - Algeria 3
EU - Europa 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
AZ - Azerbaigian 2
EG - Egitto 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
LV - Lettonia 2
MA - Marocco 2
OM - Oman 2
PY - Paraguay 2
TW - Taiwan 2
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 6.242
Città #
Fairfield 558
Ashburn 421
Woodbridge 396
Chandler 285
Singapore 256
Houston 237
Seattle 209
Ann Arbor 193
Cambridge 185
Wilmington 183
Nyköping 182
Hong Kong 163
Beijing 130
Dallas 124
New York 96
Nanjing 51
Los Angeles 50
Roxbury 47
Lawrence 46
Bari 35
Inglewood 34
Brussels 32
Munich 32
Des Moines 27
Dearborn 25
Brooklyn 24
Jacksonville 24
São Paulo 23
Dong Ket 22
Jakarta 21
Santa Clara 21
Ho Chi Minh City 20
Princeton 19
Hanoi 18
Columbus 17
The Dalles 16
San Diego 15
Council Bluffs 14
Buffalo 13
Abidjan 12
Warsaw 12
Boston 11
Denver 11
Rio de Janeiro 11
Chicago 10
Frankfurt am Main 10
Nanchang 10
Tokyo 10
Hebei 9
Helsinki 9
Pune 9
Boardman 8
Moscow 8
Shanghai 8
Shenyang 8
Belo Horizonte 7
Montreal 7
Paris 7
Chennai 6
Guangzhou 6
Jiaxing 6
Johannesburg 6
Kunming 6
London 6
Maringá 6
Phoenix 6
Tianjin 6
Toronto 6
Zhengzhou 6
Atlanta 5
Brasília 5
Curitiba 5
Dublin 5
Falkenstein 5
Ha Long 5
Haiphong 5
Hangzhou 5
Jinan 5
Johor Bahru 5
Milan 5
Mumbai 5
Nuremberg 5
Orem 5
San Francisco 5
Stockholm 5
Vienna 5
Ankara 4
Falls Church 4
Fortaleza 4
Hefei 4
Mexico City 4
Portsmouth 4
Ribeirão Preto 4
Turku 4
Cincinnati 3
Edinburgh 3
Guayaquil 3
Hounslow 3
Istanbul 3
Kilburn 3
Totale 4.642
Nome #
Obesity as predictor of postoperative outcomes in liver transplant candidates: Review of the literature and future perspectives 196
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 184
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 178
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 169
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy 169
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 164
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 162
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 162
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 161
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 153
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 140
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 135
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 132
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 131
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 128
Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: Pathogenetic mechanisms and clinical relevance 120
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 119
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 109
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 109
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 103
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 102
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 102
null 100
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 95
null 90
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 88
null 86
null 86
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 84
null 82
null 81
null 81
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 81
null 80
null 79
null 79
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 79
Assessment of body composition: Intrinsic methodological limitations and statistical pitfalls 79
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 78
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 74
null 74
null 72
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 69
null 69
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 68
null 67
Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis 67
null 66
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 66
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 65
Epstein-Barr Virus-Related hyperacute hepatitis: May intravenous Ster-Oids be an effective approach? 64
Concomitant and Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial 63
HCV-positive kidney transplant patients treated with direct-acting antivirals maintain stable medium-term graft function despite persistent reduction in tacrolimus trough levels 61
null 59
null 59
New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study 58
Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? 56
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta-analysis of randomized controlled trials 55
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association 53
Familial intestinal polyposis and device assisted enteroscopy: where do we stand? 52
Sequential therapy for helicobacter pylori in elderly patients: Effectiveness, safety and predictors of success 52
Epithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors? 52
Transmission electron microscopy helpfulness in Whipple's disease masked by immunosuppressant therapy for arthritis 50
Impact of Bifidobacterium longum Subspecies infantis on Pediatric Gut Health and Nutrition: Current Evidence and Future Directions 47
Helicobacter pylori Secondary Antibiotic Resistance after One or More Eradication Failure: A Genotypic Stool Analysis Study 46
Effect of Visual Booklets to Improve Bowel Preparation in Colonoscopy: Systematic Review with Meta-Analysis 43
null 42
Natural History and Hepatitis B Virus Surface Antigen (HBsAg) Spontaneous Seroclearance in Hepatitis B Virus e-Antigen (HBeAg)-Negative Patients with Inactive Chronic Infection: A Multicenter Regional Study from South Italy 41
The Interaction Between Celiac Disease and Intestinal Microbiota 41
Helicobacter pylori, liver cirrhosis, and portal hypertension: an updated appraisal 41
null 39
Letter: Could sequential therapy extended to 14 days replace prolonged triple regimens for Helicobacter pylori treatment? 39
null 36
Novel frontiers of agents for bowel cleansing for colonoscopy 30
Seronegative Celiac Disease and immunoglobulin deficiency: Where to look in the submerged iceberg? 28
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens? 27
null 13
Totale 6.560
Categoria #
all - tutte 27.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021491 0 0 0 0 0 45 98 123 23 107 37 58
2021/2022427 52 8 15 19 19 37 15 27 27 38 66 104
2022/2023695 87 115 59 57 56 104 9 84 90 4 16 14
2023/2024265 16 41 9 27 17 106 7 5 2 15 5 15
2024/20251.072 22 19 58 25 40 97 174 114 39 70 142 272
2025/20261.338 393 134 242 207 334 28 0 0 0 0 0 0
Totale 6.560